Drawing for INFINIPLEX

USPTO serial 79226633

INFINIPLEX

Reviewed by CopyMark Law Group

Reg. 5808926Status 707Registered
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
TORRES, ELIANA
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with INFINIPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas N. Masters

Douglas N. Masters Loeb & Loeb LLP321 North Clark Street, Suite 2300Chicago, IL 60654United States

Goods and services

ClassDescriptionStatusFirst use
001chemicals used in industry and science; [ chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; ] chemical reagents for non-medical purposes; enzymes and proteins for scientific and research purposes; diagnostic preparations for scientific purposes; kits comprised primarily of diagnostic preparations for analysis of food products [ and water ] for scientific and research use; chemical diagnostic reagents for industrial use; chemical diagnostic scanning agents for industrial use; diagnostic testing materials, namely, diagnostic preparations other than for medical use [ ; chemical reagents for use in diagnostic tests other than for medical or veterinary use ]ACTIVE—
005Pharmaceutical, veterinary preparations and substances for the detection of drug residues, namely, antibiotic, non-steroidal anti-inflammatory and anti-parasitic residues; [ sanitary preparations for medical use; antitoxic sera and pharmaceutical preparations in the nature of antisera for the detection of drug Residues, namely, antibiotic, non-steroidal anti-inflammatory and anti-parasitic residues; diagnostic preparations for medical purposes; kits comprised of diagnostic preparations for medical purposes; ] clinical diagnostic preparations for [ medial and ] veterinary use; diagnostic testing preparations for [ medical and ] veterinary use; clinical diagnostic reagents for in vitro [ and/or vivo] use; [ diagnostic scanning agents for medical purposes; ] clinical diagnostics preparation for [ medical and ] veterinary use; [ diagnostic testing preparations for medical and veterinary use; clinical medical reagents; clinical medical reagents; ] reagents for use in diagnostic tests for [ medical and ] veterinary purposes; reagents for use with analyzers for [ medical and ] veterinary purposesACTIVE—
009[ Scientific, nautical, surveying, optical, weighing, measuring, signaling, checking supervision, life-rescue and teaching apparatus and instruments, namely, cuvettes wash station, chemical reagent carousel in the nature of automated reagent sample processing apparatus, chemical reagent sample carousel, chemical reaction carousel in the nature of automated reagent sample processing apparatus, cuvettes and pipettes; data processing equipment and computers; ] computer software and computer programs for analysis, monitoring, research and reporting of [ medical and ] clinical data; computer software programs for accessing data from computer databases for use in analysis, monitoring, research and reporting of [ medical and ] clinical data; [ computer hardware and computer systems composed of computer hardware and computer software all for the analysis, monitoring, research and reporting of medical and clinical data; electronic publications, namely, magazines, newsletters, journals, periodical publications, manuals, featuring information about the analysis, monitoring, research and/or reporting of medical and clinical data; scientific and optical apparatus and instruments for the analysis, monitoring, research and reporting of medical and clinical data, namely, cuvettes wash station, chemical reagent carousel in the nature of automated reagent sample processing apparatus, chemical reagent sample carousel, chemical reaction carousel in the nature of automated reagent sample processing apparatus, cuvettes and pipettes; ] diagnostic testing apparatus and instruments for detection of restricted drugs for use in immunoassay procedures, not for medical purposes; downloadable electronic publications in the nature of brochures, product manuals, [ safety data sheets, white papers ] and posters in the field of clinical chemistry testing, veterinary, toxicology, protein and genetic research; biochips for research or scientific purposes; [ incubators for laboratory use; detectors, namely, a charge coupled device camera for measuring the generation of light from a chemiluminescence reaction; ] diagnostic apparatus and instruments for detection of restricted drugs, not for medical purposes; diagnostic imaging apparatus used for clinical chemistry testing, veterinary, toxicology, protein and genetic research, other than for medical use [ ;clinical laboratory analytical instruments used for testing and diagnostic services for others in the fields of science and research related thereto, other than for medical use, namely, cuvettes wash station, chemical reagent carousel in the nature of automated reagent sample processing apparatus, chemical reagent sample carousel, chemical reaction carousel in the nature of automated reagent sample processing apparatus, cuvettes and pipettes ]ACTIVE—
010[ diagnostic imaging apparatus for medical use, namely a charge coupled device camera for measuring the generation of light from a chemiluminescence reaction; clinical chemistry analyzers for use in analyzing biological samples for medical and veterinary use; ] diagnostic testing apparatus and instruments for detection of antibiotics / non-steroidal, anti-inflamatory and anti-parasitic drug residues used in immunoassay procedures for use in immunoassay procedures; clinical laboratory analytical instruments for medical and veterinary use for the detection of antibiotics / non-steroidal, anti-inflammatory and anti-parasitic drug residuesACTIVE—
042[ Scientific and technological services and research and design in the nature of scientific research, analysis and design in the field of food testing, veterinary, toxicology, and food research provided for clinical laboratories, university and education institutes, research laboratories, veterinary laboratories and food and wine laboratories; medical research services; clinical research services, namely, for research of immunoassay technology, biotechnology, veterinary, toxicology, protein and food and wine testing; biological research; analysis, management and reporting of clinical data namely, immunoassay technology, veterinary, toxicology, protein, food and wine and research data; consulting services in the field of quality assessment services for clinical laboratories; chemical research; chemical laboratory services; chemical analysis; laboratory services for analytical testing; medical laboratory services; conducting clinical trials for others; computer aided diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; development of test equipment for medical apparatuses for others; advice, information and consultancy services relating to all the aforesaid services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 26, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 26, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 21, 2026ES71TEAS SECTION 71 RECEIVED—
Jul 23, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 9, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 6, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 14, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 14, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 2, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 17, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2019GPNXNOTIFICATION PROCESSED BY IB—
Apr 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 16, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 16, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 16, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 18, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 18, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 18, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 6, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 6, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 6, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2018RFNPREFUSAL PROCESSED BY IB—
Mar 12, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 12, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2018RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Feb 28, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 27, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 23, 2018DOCKASSIGNED TO EXAMINER—
Feb 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance